|
||||||
|
 | |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
|
Gene: ENSG00000266074 |
Summary for BAHCC1 |
 Gene summary |
| Gene information | Ensembl ID | ENSG00000266074 | Gene symbol | BAHCC1 |
| Gene name | BAH domain and coiled-coil containing 1 | |
| HGNC | 29279 | |
| Entrez ID | 57597 | |
| Gene type | protein_coding | |
| Synonyms | BAHCC1|KIAA1447|BAHD2 | |
| UniProtAcc | Q9P281 |
| Drugs associated with this gene(DrugBank). |
| Gene ID | Gene Symbol | Drug ID | Drug Name | Drug Type |
| Cancer therapeutic drugs associated with this gene(NCI). |
| Gene ID | Gene Name | Drug ID | Drug Name | Drug Type | Cancer |
Top |
Structure and expression level for BAHCC1 |
| AS events and RNA A-to-I editing events of the gene in TCGA based on Genvode V22 structure. ∗For more information on exon skipping events please check the ExonskipDB database. ∗For more information on exon skipping events please check the CAeditome database. |
 |
| Landscape of gene expressions across multiple cancer types. |
 |
| Differentially expressed gene analysis between tumor male and tumor female samples. |
 |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| BAHCC1 | 7.17e+02 | -1.13e+00 | 3.43e-01 | -3.30e+00 | 9.65e-04 | 3.48e-02 | ACC |
| Differentially expressed gene analysis between tumor male and normal male samples. |
 |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| BAHCC1 | 6.84e+02 | -1.36e+00 | 2.50e-01 | -5.44e+00 | 5.26e-08 | 2.31e-07 | KIRP |
| BAHCC1 | 1.25e+03 | 1.34e+00 | 3.14e-01 | 4.27e+00 | 1.94e-05 | 1.02e-04 | CHOL |
| Differentially expressed gene analysis between tumor female and normal female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
Top |
Sex-biased somatic mutation for BAHCC1 |
| ∗For more information on exon skipping events please check the ExonskipDB database. |
| Gene ID | Cancer Type | Hugo Symbol | Male | Female | pval | or | ci.up | ci.low | adjPval |
Top |
DNA methylation with beta values for BAHCC1 |
| Landscape of DNA methylation across multiple cancer types. |
 |
| Differentially expressed CpG sites between male tumor and female tumor patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| Differentially expressed CpG sites between male tumor and male normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| Differentially expressed CpG sites between female tumor and female normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| BLCA | cg07906179 | chr17:81394607 | CGI:chr17:81393006-81400942 | promoter | 6.21e-01 | 5.01e-01 | 2.39e+00 | 1.70e-02 | 2.44e-02 | 1.20e-01 |
Top |
Exon skipping events with PSI in TCGA for BAHCC1 |
| ∗Please access ExonSkipDB for exon skipping annotation. |
| Differentially expressed exon skipping events between male tumor and female tumor patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| Differentially expressed exon skipping events between male tumor and male normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| Differentially expressed exon skipping events between female tumor and female normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Top |
RNA A-to-I editing events in TCGA for BAHCC1 |
| ∗Please access CAeditome for RNA editing annotation. |
| Differentially expressed RNA editing events between male tumor and female tumor patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Differentially expressed RNA editing events between male tumor and male normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Differentially expressed RNA editing events between female tumor and female normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Protein coding RNA editing(s). |
| Editing Position | Variant Type | Gene Symbol | Transcript ID | NTchange | AAchange |
Top |
Sex-biased TF-Gene network for BAHCC1 |
| TFs related to BAHCC1. ∗The female-biased TF-gene edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased TF-gene edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | TF | Target Gene | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| BAHCC1 related gene. ∗Only the gene encode TF might with this result. ∗For more information please check Sex-biased TF-Coding gene network. |
Top |
Sex-biased RBP-ES network for BAHCC1 |
| RBPs related to ES in BAHCC1. ∗The female-biased RBP-ES edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased RBP-ES edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | RBP | Target ES | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| BAHCC1 related ES. ∗Only the gene encode RBP might with this result. ∗For more information please check Sex-biased RBP-ES network in cancer. |
Top |
Sex-biased CeRNA regulation of gene |
| Sex-biased CeRNA regulation of gene. |
| Gene ID | ceRNA(lncRNA-miRNA-mRNA) | Group | Cancer Type |
Top |
Sex-biased eQTL regulation of gene |
| Sex-biased eQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| eQTL | Description |
| Male-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs12943442 | chr17:74483320:C:A | - | 0.21448522115339 | 0.00634366284413429 | GBM | Female-baised eQTL |
| rs9944466 | chr17:74483694:T:C | - | 0.171207555627502 | 0.0236176438955209 | GBM | Female-baised eQTL |
| rs9903890 | chr17:74484328:A:G | - | 0.171207555627502 | 0.0236176438955209 | GBM | Female-baised eQTL |
| rs9915892 | chr17:74485841:G:A | - | 0.171207555627502 | 0.0236176438955209 | GBM | Female-baised eQTL |
| rs7225476 | chr17:80587803:G:A | - | -0.0649422081805975 | 0.018917151886261 | LUAD | Female-baised eQTL |
| rs12943585 | chr17:82982911:T:C | - | 0.126210011566708 | 0.0178211982399251 | COAD | Female-baised eQTL |
| rs1006589 | chr17:79267051:T:C | - | -0.0526681951724277 | 0.026320950121719 | COAD | Female-baised eQTL |
| Female-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs73414705 | chr17:79865596:T:C | - | 0.235432230619299 | 0.0106354939200301 | SARC | Male-baised eQTL |
| rs73414717 | chr17:79867798:G:A | - | 0.235539878626113 | 0.0106383921137692 | SARC | Male-baised eQTL |
| rs4889789 | chr17:79865774:T:C | - | 0.23453787028041 | 0.0113273293235053 | SARC | Male-baised eQTL |
| rs4889793 | chr17:79866288:C:T | - | 0.233538695179078 | 0.0122603352819631 | SARC | Male-baised eQTL |
| rs4889912 | chr17:79866301:A:G | - | 0.233538695179078 | 0.0122603352819631 | SARC | Male-baised eQTL |
| rs2120458 | chr17:79866479:A:G | - | 0.233538695179078 | 0.0122603352819631 | SARC | Male-baised eQTL |
| rs35817640 | chr17:79866720:T:C | - | 0.233538695179078 | 0.0122603352819631 | SARC | Male-baised eQTL |
| rs12450235 | chr17:79867123:A:G | - | 0.233538695179078 | 0.0122603352819631 | SARC | Male-baised eQTL |
| rs12452145 | chr17:79867126:G:T | - | 0.233538695179078 | 0.0122603352819631 | SARC | Male-baised eQTL |
| rs77094445 | chr17:79868487:A:G | - | 0.232314373870572 | 0.0135195850634035 | SARC | Male-baised eQTL |
| rs56354553 | chr17:74564554:C:G | - | 0.149732320772998 | 0.0150423423013647 | SARC | Male-baised eQTL |
| rs7208733 | chr17:76804917:T:C | - | -0.106555821559318 | 0.00458584408359446 | LGG | Male-baised eQTL |
| rs7209901 | chr17:76805793:A:G | - | -0.113310611789962 | 0.0046910758598297 | LGG | Male-baised eQTL |
| rs6501922 | chr17:76802654:A:G | - | -0.106423862099585 | 0.00550220262077886 | LGG | Male-baised eQTL |
| rs7224332 | chr17:76805142:A:G | - | -0.104158107006941 | 0.00809341806824815 | LGG | Male-baised eQTL |
| rs7210079 | chr17:76805911:A:G | - | -0.104158107006941 | 0.00809341806824815 | LGG | Male-baised eQTL |
| rs2172213 | chr17:76806177:T:C | - | -0.104158107006941 | 0.00809341806824815 | LGG | Male-baised eQTL |
| rs4605193 | chr17:76801208:A:G | - | -0.106698318719437 | 0.0109077258433095 | LGG | Male-baised eQTL |
| rs9900513 | chr17:76802292:A:G | - | -0.0937646839039583 | 0.0247126094200256 | LGG | Male-baised eQTL |
| rs6501923 | chr17:76803775:T:C | - | -0.100635427245938 | 0.0300131385701624 | LGG | Male-baised eQTL |
| rs16976613 | chr17:71417660:A:G | - | 0.0607593569404645 | 0.0367773891936737 | LUAD | Male-baised eQTL |
| rs55768663 | chr17:75493955:C:T | - | 0.121676363565831 | 0.0437449191412373 | COAD | Male-baised eQTL |
| Opposite sex-biased eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Sex-biased Gene in Cancer | Cancer Type |
Top |
Sex-biased eQTM regulation of gene |
| Sex-biased eQTM regulation of gene (The figures only show the pairs with FDR<1e-5. For more information please check the below table). |
| eQTM | Description |
 | Gene ID: ENSG00000266074 |
| CpG Site: cg11848015 | |
| Position to Gene: gene,exon,UTR | |
| Male Effect: -0.215643223398517 | |
| Female Effect: - | |
 | Gene ID: ENSG00000266074 |
| CpG Site: cg17781958 | |
| Position to Gene: gene,exon,CDS | |
| Male Effect: - | |
| Female Effect: -0.412375659339075 | |
 | Gene ID: ENSG00000266074 |
| CpG Site: cg11848015 | |
| Position to Gene: gene,exon,UTR | |
| Male Effect: - | |
| Female Effect: -0.412375659339075 | |
 | Gene ID: ENSG00000266074 |
| CpG Site: cg03954280 | |
| Position to Gene: gene,exon,UTR | |
| Male Effect: - | |
| Female Effect: -0.316627479905264 | |
 | Gene ID: ENSG00000266074 |
| CpG Site: cg20428133 | |
| Position to Gene: gene | |
| Male Effect: - | |
| Female Effect: -0.412503443162235 | |
 | Gene ID: ENSG00000266074 |
| CpG Site: cg24550880 | |
| Position to Gene: gene | |
| Male Effect: - | |
| Female Effect: -0.412503443162235 | |
 | Gene ID: ENSG00000266074 |
| CpG Site: cg21284015 | |
| Position to Gene: gene | |
| Male Effect: - | |
| Female Effect: -0.411790365807533 |
| Male-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| cg11848015 | chr17:81466124 | gene,exon,UTR | -0.215643223398517 | 4.56853550800677e-11 | -0.47758112914846 | 4.172069968153334e-14 | LUAD |
| Female-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| cg17781958 | chr17:81461378 | gene,exon,CDS | -0.412375659339075 | 5.41543857509815e-09 | -0.491755840671972 | 2.741228579138475e-12 | SKCM |
| cg11848015 | chr17:81466124 | gene,exon,UTR | -0.412375659339075 | 5.41543857509815e-09 | -0.491755840671972 | 2.741228579138475e-12 | SKCM |
| cg03954280 | chr17:81463920 | gene,exon,UTR | -0.316627479905264 | 8.29289361917676e-05 | -0.36991138508295074 | 3.462685931398636e-07 | SKCM |
| cg20428133 | chr17:81415014 | gene | -0.412503443162235 | 3.59630159497076e-07 | -0.555132745741518 | 3.7427583766552085e-10 | BLCA |
| cg24550880 | chr17:81453253 | gene | -0.412503443162235 | 3.59630159497076e-07 | -0.555132745741518 | 3.7427583766552085e-10 | BLCA |
| cg21284015 | chr17:81453220 | gene | -0.411790365807533 | 3.895805231865e-07 | -0.5634451887557814 | 8.55813107276999e-10 | BLCA |
| Opposite sex-biased eQTM regulation. |
| CpG Site | CpG Postion | CpG Island | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Male Cor | Male P-value | Female Cor | Female P-value | Sex-biased Coding Gene | Cancer Type |
Top |
Sex-biased sQTL regulation of gene |
| Sex-biased sQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTL | Description |
| Male-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| Female-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| Opposite sex-biased sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Male Effect | Male FDR | Female Effect | Female FDR | Cancer Type |
Top |
Sex-biased sQTM regulation of gene |
| Sex-biased sQTM regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTM | Description |
| Male-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| Female-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| Opposite sex-biased sQTM regulation. |
| EX ID | EX Info | Skipped Exon | CPG Site | CPG Position | CPG Island | Position to EX Events | Male Effect | Male FDR | Female Effect | Female FDR | Male Correlation | Male P-value | Female Correlation | Female P-value | ORF_anno | Cancer Type |
Top |
Related disease information of BAHCC1 |
| Diseases associated with this gene (DisGeNET). |
| Gene ID | Gene Symbol | Disease ID | Disease Name | Number of PMID | Source |
